Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $335.55 | 12 | 96.3% |
| Education | $12.85 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $56.09 | 1 | $0 (2017) |
| Boston Scientific Corporation | $52.69 | 2 | $0 (2023) |
| Alkermes, Inc. | $51.58 | 3 | $0 (2021) |
| Arbor Pharmaceuticals, Inc. | $46.99 | 1 | $0 (2017) |
| Purdue Pharma L.P. | $46.99 | 1 | $0 (2017) |
| Indivior Inc. | $43.41 | 2 | $0 (2023) |
| Orexo US, Inc. | $31.36 | 2 | $0 (2018) |
| Gilead Sciences, Inc. | $19.29 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $96.10 | 4 | Boston Scientific Corporation ($52.69) |
| 2022 | $19.29 | 1 | Gilead Sciences, Inc. ($19.29) |
| 2021 | $18.63 | 1 | Alkermes, Inc. ($18.63) |
| 2019 | $32.95 | 2 | Alkermes, Inc. ($32.95) |
| 2018 | $13.16 | 1 | Orexo US, Inc. ($13.16) |
| 2017 | $168.27 | 4 | Valeant Pharmaceuticals North America LLC ($56.09) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 07/18/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: OUD | ||||||
| 06/14/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 05/09/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: OUD | ||||||
| 11/01/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.29 | General |
| 04/21/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: CNS | ||||||
| 09/21/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: CNS | ||||||
| 09/20/2019 | Alkermes, Inc. | Vivitrol (Drug) | Education | In-kind items and services | $12.85 | General |
| Category: CNS | ||||||
| 08/31/2018 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $13.16 | General |
| Category: Addiction Medicine | ||||||
| 10/13/2017 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: Addiction Medicine | ||||||
| 06/03/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $56.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2017 | Purdue Pharma L.P. | — | Food and Beverage | Cash or cash equivalent | $46.99 | General |
| 06/03/2017 | Arbor Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $46.99 | General |
| Category: Sleep | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 31 | 61 | $25,350 | $6,024 |
| 2022 | 3 | 50 | 99 | $20,000 | $5,760 |
| 2021 | 3 | 91 | 112 | $63,889 | $17,529 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 2023 | 12 | 21 | $23,100 | $5,530 | 23.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 19 | 40 | $2,250 | $494.00 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 34 | $10,190 | $3,074 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 42 | $8,775 | $2,402 | 27.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 13 | 23 | $1,035 | $284.30 | 27.5% |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 2021 | 48 | 49 | $53,900 | $13,082 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 43 | $4,989 | $2,490 | 49.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 20 | $5,000 | $1,957 | 39.1% |
About Dr. Verna Bain, MD
Dr. Verna Bain, MD is a Internal Medicine healthcare provider based in Portland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396816997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Verna Bain, MD has received a total of $348.40 in payments from pharmaceutical and medical device companies, with $96.10 received in 2023. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($335.55).
As a Medicare-enrolled provider, Bain has provided services to 172 Medicare beneficiaries, totaling 272 services with total Medicare billing of $29,313. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Addiction Medicine, Sleep Medicine
- Location Portland, TN
- Active Since 11/13/2006
- Last Updated 12/12/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396816997
Products in Payments
- RELISTOR (Drug) $56.09
- Horizant (Drug) $46.99
- SUBLOCADE (Drug) $43.41
- VIVITROL (Drug) $38.73
- Zubsolv (Drug) $31.36
- Vivitrol (Drug) $12.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078